Evidence map›Paper›PMID 28434548›Full record

ArticleThe Annals of thoracic surgery2017

Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury.

J Hunter Mehaffey, Eric J Charles, Ashish K Sharma, Morgan Salmon, Dustin Money, Sarah Schubert, Mark H Stoler, Curtis G Tribble, Victor E Laubach, Mark E Roeser and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Annals of thoracic surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Journal of thoracic disease · 2019
    Article
  13. In vivo lung perfusion rehabilitates sepsis-induced lung injury.The Journal of thoracic and cardiovascular surgery · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

J Hunter MehaffeyDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Eric J CharlesDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Ashish K SharmaDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Morgan SalmonDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Dustin MoneyDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Sarah SchubertDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Mark H StolerDepartment of Pathology, University of Virginia, Charlottesville, Virginia.
Curtis G TribbleDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Victor E LaubachDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Mark E RoeserDepartment of Surgery, University of Virginia, Charlottesville, Virginia.
Irving L KronDepartment of Surgery, University of Virginia, Charlottesville, Virginia. Electronic address: ilk@virginia.edu.
University of Virginia · US

Funding

Cardiovascular Surgery Training ProgramT32HL007849 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KRON, IRVING L., LAUBACH, VICTOR E · 1998 to 2025
$7.0M
Ex vivo perfusion in a lung box for rehabilitation of donor lungsR01HL119218 · NHLBI · UNIVERSITY OF VIRGINIA · PI KRON, IRVING L., LAUBACH, VICTOR E · 2013 to 2017
$3.3M
NHLBI NIH HHS R01 HL119218NHLBI NIH HHS T32 HL007849
6 · The paper itself

Abstract

backgroundSepsis is the number one cause of lung injury in adults. Ex vivo lung perfusion (EVLP) is gaining clinical acceptance for donor lung evaluation and rehabilitation and may expand the use of marginal organs for transplantation. We hypothesized that 4 hours of normothermic EVLP would improve compliance and oxygenation in a porcine model of sepsis-induced lung injury.

methodsWe used intravenous lipopolysaccharide (LPS) to induce a systemic inflammatory response in a porcine model of lung injury. Two groups of 4 animals each received a 2-hour infusion of LPS through the external jugular vein. Serial measurements of blood gases were performed every 30 minutes until the partial pressure of oxygen/fraction of inspired oxygen ratio dropped below 150 on two consecutive readings. Lungs were then randomized to treatment with 4 hours of normothermic EVLP with STEEN Solution (XVIVO Perfusion Inc, Englewood, CO) or 4 additional hours of in vivo perfusion (control). Airway pressures and blood gases were recorded for calculation of dynamic lung compliance and partial pressure of oxygen/fraction of inspired oxygen ratios. EVLP was performed with hourly recruitment maneuvers and oxygen challenge.

resultsAll animals reached a partial pressure of oxygen/fraction of inspired oxygen ratio of less than 150 mm Hg within 3 hours after start of the LPS infusion. Oxygenation and compliance in the control animals continued to decline during the 4-hour in vivo perfusion period, and 3 of the 4 animals died of severe hypoxia within 4 hours. The EVLP group demonstrated significant improvements hour 1 to hour 4 in oxygenation (365.8 ± 53.0 vs 584.4 ± 21.0 mm Hg, p = 0.02) and dynamic compliance (9.0 ± 2.8 vs 15.0 ± 3.6, p = 0.02 mL/cm H

conclusionsEVLP successfully rehabilitated LPS-induced lung injury in this preclinical porcine model and may thus provide a means to rehabilitate many types of acute lung injury.

Indexed as

PerfusionAnimalsDisease Models, AnimalFemaleLipopolysaccharidesLung InjuryLung TransplantationMaleOrgan Preservation SolutionsRandom AllocationRespiratory Distress SyndromeSepsisSwineLipopolysaccharidesOrgan Preservation Solutions

Identifiers

PMID28434548
PMCPMC5438908
OpenAlexW2605860910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.